HomeCompareOISXF vs JNJ

OISXF vs JNJ: Dividend Comparison 2026

OISXF yields 1.25% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $8.8K in total portfolio value· pulled ahead in Year 6
10 years
OISXF
OISXF
● Live price
1.25%
Share price
$7.47
Annual div
$0.09
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.5K
Annual income
$135.88
Full OISXF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — OISXF vs JNJ

📍 JNJ pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOISXFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OISXF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OISXF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OISXF
Annual income on $10K today (after 15% tax)
$106.49/yr
After 10yr DRIP, annual income (after tax)
$115.50/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,870.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OISXF + JNJ for your $10,000?

OISXF: 50%JNJ: 50%
100% JNJ50/50100% OISXF
Portfolio after 10yr
$25.9K
Annual income
$2,412.64/yr
Blended yield
9.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OISXF
No analyst data
Altman Z
3.0
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OISXF buys
0
JNJ buys
0
No recent congressional trades found for OISXF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOISXFJNJ
Forward yield1.25%2.13%
Annual dividend / share$0.09$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$21.5K$30.3K
Annual income after 10y$135.88$4,689.40
Total dividends collected$1.3K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OISXF vs JNJ ($10,000, DRIP)

YearOISXF PortfolioOISXF Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,825$125.28$10,592$272.30+$233.00OISXF
2$11,710$126.75$11,289$357.73+$421.00OISXF
3$12,658$128.13$12,123$472.89+$535.00OISXF
4$13,673$129.44$13,141$629.86+$532.00OISXF
5$14,761$130.68$14,408$846.81+$353.00OISXF
6← crossover$15,926$131.85$16,021$1,151.60$95.00JNJ
7$17,174$132.95$18,122$1,588.22$948.00JNJ
8$18,510$133.99$20,930$2,228.20$2.4KJNJ
9$19,941$134.96$24,792$3,191.91$4.9KJNJ
10$21,472$135.88$30,274$4,689.40$8.8KJNJ

OISXF vs JNJ: Complete Analysis 2026

OISXFStock

Oisix ra daichi Inc. engages in the online and catalogue sale of organic vegetables, agricultural products, additive free processed foods, and other food products and ingredients to general consumers in Japan. The company offers food products through Oisix stores; Oisix order services that enables consumers to order hard to find seasonal products; Oitoku, a regular delivery services that provides customers with pre-registered products at discounted prices; Daichi wo mamorukai, a household delivery services for organic agricultural products; and Tavelty for seasonal vegetable novelty packs. In addition, it offers advertising services; solutions support to companies for repeat sales; website user interface/user experience enhancement; temperature-controlled food distribution; new online customer acquisitions; and know-how on omni-channel retailing. The company was formerly known as Oisix.daichi Inc., and changed its name to Oisix ra daichi Inc. in July 2018. Oisix ra daichi Inc. was incorporated in 1997 and is headquartered in Tokyo, Japan.

Full OISXF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this OISXF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OISXF vs SCHDOISXF vs JEPIOISXF vs OOISXF vs KOOISXF vs MAINOISXF vs ABBVOISXF vs MRKOISXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.